NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Category: clinical trials

9/24/2020

How COVID-19 drug/vaccine decisions might be based on little evidence

4/17/2020

Slow down your giddyup on Gilead news

10/22/2019

How one bit of medical jargon fuels public confusion about cancer treatments

2 11/13/2018

‘Historic breakthrough Alzheimer patients around the globe have been awaiting’

6/25/2018

‘Home run’ gene therapy for Duchenne muscular dystrophy: Investor-oriented coverage pitches promise but …

1 4/19/2018

Between news release hype and peer-reviewed publication, patients wait in limbo

4/13/2018

5-Star Friday: Drugs, mice, and money

1 4/5/2018

Ethicists find fault with cancer centers marketing their clinical trials as a patient benefit